Lombard Odier Asset Management Europe Ltd Has $4.95 Million Position in Danaher Corporation $DHR

Lombard Odier Asset Management Europe Ltd lessened its position in Danaher Corporation (NYSE:DHRFree Report) by 54.5% in the 1st quarter, Holdings Channel reports. The firm owned 26,109 shares of the conglomerate’s stock after selling 31,312 shares during the period. Lombard Odier Asset Management Europe Ltd’s holdings in Danaher were worth $4,950,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in DHR. Main Street Group LTD acquired a new position in shares of Danaher in the 1st quarter valued at $25,000. JPL Wealth Management LLC acquired a new stake in Danaher during the 3rd quarter worth $25,000. Elevated Capital Advisors LLC bought a new position in Danaher during the fourth quarter worth about $26,000. WFA of San Diego LLC bought a new position in Danaher during the second quarter worth about $26,000. Finally, Hilton Head Capital Partners LLC acquired a new position in Danaher in the fourth quarter valued at about $27,000. 79.05% of the stock is owned by institutional investors.

Danaher Stock Performance

DHR opened at $191.87 on Friday. The company has a market capitalization of $134.88 billion, a price-to-earnings ratio of 34.08, a P/E/G ratio of 2.38 and a beta of 0.79. The business’s 50-day moving average price is $185.64 and its two-hundred day moving average price is $197.04. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.52.

Danaher (NYSE:DHRGet Free Report) last posted its quarterly earnings data on Tuesday, July 21st. The conglomerate reported $1.94 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.Danaher’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.77 earnings per share. Equities analysts expect that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.8%. Danaher’s payout ratio is presently 28.42%.

Analysts Set New Price Targets

Several brokerages have issued reports on DHR. The Goldman Sachs Group lowered their price target on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Monday, April 13th. Royal Bank Of Canada boosted their price objective on Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research report on Wednesday. Citigroup started coverage on Danaher in a research note on Tuesday, May 26th. They set a “buy” rating and a $230.00 target price for the company. Morgan Stanley dropped their target price on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. Finally, HSBC cut their price target on shares of Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.

Read Our Latest Research Report on DHR

Danaher News Summary

Here are the key news stories impacting Danaher this week:

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.